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ABSTRACT 
 
 
A limited number of ß-adrenergic agonists (ß-AA) are currently used for 
redirecting dietary energy from adipose tissue accretion towards muscle growth.  At the 
end of typical feedlot finishing, cattle have depressed insulin sensitivity, similar to type 
II diabetes in humans.  The objective of this study was to compare the effects of a known 
β3-AA (BRL 37344) to a novel ß-AA (Experior) on muscle metabolism in vitro.  We 
hypothesized that Experior would attenuate insulin insensitivity by promoting glucose 
metabolism in muscle.  The M. longissimus lumborum (LL) was removed from the 9th to 
11th rib from four steers.  From the LL samples, muscle strips were dissected parallel to 
muscle fiber orientation.  The conversion of glucose to glycogen, CO2, and lactate was 
tested in muscle strips incubated for 90 min with 50 µM Experior, 50 µM BRL 37344, 
or no β-AA (Control), and different insulin concentrations.  Incubation time was 
established by a preliminary experiment that determined the effect of different 
incubation times (30 min, 60 min, 90 min) on glycogen, CO2, and lactate production.  
There were no (P > 0.05) insulin concentration x treatment effects, insulin concentration 
effects, and no significant effect of treatment on lactate production.  There was a 
significant treatment effect of conversion of glucose to glycogen (P < 0.001) and CO2 (P 
= 0.018).  BRL 37344 caused 62% lower glycogen production compared to Control 
samples, and 50% lower glycogen production compared to Experior samples.  Control 
samples produced 4.3 nmol/100 mg·90 min, Experior samples produced 3.1 nmol/100 
mg·90 min glycogen, while BRL 37344 samples produced 1.6 nmol/100 mg·90 min.  
BRL 37344 elicited 23% more CO2 than Experior, and 41% more CO2 than Control 
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samples.  Control samples produced 171.3 nmol/100 mg·90 min CO2, Experior samples 
produced 222.9 nmol/100 mg·90 min CO2, while BRL 37344 samples produced 292.6 
nmol/100 mg·90 min CO2.  Experior did not have a consistent effect on glycogen or CO2 
production.  We discovered the presence of ß3- AR in muscle, since there was a distinct 
response of the muscle strips to BRL 37344.  The relative insensitivity of bovine muscle 
to insulin is consistent with insulin resistance observed in feedlot cattle.  
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NOMENCLATURE 
β-AA β-adrenergic agonist 
LL M. longissimus lumborum 
G6P Glucose-6-phosphate 
F6P Fructose-6-phosphate 
F-1, 6-P2 Fructose 1-6 bisphosphate 
TCA Tricarboxylic acid cycle 
ETC Electron transport chain 
G1P Glucose-1-phosphate 
PEP Phosphoenol pyruvate 
OAA Oxaloacetate 
PEPcarboxykinase Phosphoenol pyruvate carboxykinase 
ATP Adenosine tripolyphosphate 
ADP Adenosine diphosphate 
cAMP Cyclic adenosine monophosphate 
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CHAPTER I 
INTRODUCTION 
 
1.1 Background 
Total U.S. beef consumption for the year 2017 was 56.8 billion pounds (USDA, 
2017), increasing the pressure on beef cattle producers to maintain a consistent quantity 
of red meat.  In an effort to increase red meat production in livestock in the United 
States, laboratories began developing chemical compounds that would redirect energy 
from adipose tissue deposition to muscle production (Anderson, Moody, and Hancock, 
2004).  The resulting compounds were β-AA.  Since β-AA repartition energy from 
adipose tissue growth to muscle growth, they are referred to as repartitioning agents 
(Ricks et al., 1984).  These compounds, however, do not change organ or bone mass 
(Beermann, 2002), resulting in heavier carcasses due to an increase in muscle mass.  
Most β-AA are sold as feed additives (Centner et al., 2014). 
Along with being used as repartitioning agents, β-AA also have beneficial 
pharmacological effects.  As energy is shunted to muscle production instead of fat 
production, glycogen (stored energy) is broken down and released as either glucose or 
glucose-6-phosphate (G6P).  Increased blood glucose concentrations cause insulin to be 
released from the pancreas to regulate glucose homeostasis.  If β-AA could indirectly 
increase blood glucose levels via glycogen breakdown, they could increase insulin 
sensitivity in cattle.  One study with finishing cattle reported the cattle to be insulin 
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resistant (Schoonmaker et al., 2003).  The laboratories of Dr. B. J. Johnson (Texas Tech 
University) and S. B. Smith (Texas A&M University) reported the novel finding that 
bovine muscle satellite cells express the β3-AA receptor (AR) (Miller et al., 2012).  This 
was the first study that associated β3-AA with muscle.  The original theory was that β3-
AR only resided on brown or white adipose tissue.  However, no studies have 
documented the effects of specific β3-AA on muscle metabolism.  There could be 
potential health benefits in livestock resulting in a net increase in red meat production 
and a net decrease in adipose tissue production from these findings.  In this study, the 
objective was to compare the effects of a known β3-AA (BRL 37344) to a novel ß-AA 
(Experior) on muscle metabolism in vitro.  We hypothesized that Experior would 
produce similar results to BRL 37344 and attenuate insulin insensitivity by promoting 
glucose metabolism in muscle. 
 
1.2 Muscle ultrastructure 
Muscle is a unique tissue in the body.  In the living animal, muscle is the 
working tissue that turns chemical energy into mechanical energy, allowing movement 
of the skeletal system that translates into phenomena such as locomotion and breathing.  
In the post-mortem animal, muscle is the tissue that is converted to edible meat.  Meat is 
composed of many essential nutrients, including the essential amino acids, the Vitamin 
B-complex, iron, and fatty acids (Lawrie and Ledward, 2006). 
Basic muscle tissue structure consists of stromal, sarcoplasmic, and myofibrillar 
proteins.  Stromal proteins are the connective tissues that have various jobs in the body, 
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including connecting muscle to bone, connecting bone to bone, and providing structure 
to organs and cells.  The sarcoplasmic proteins, hemoglobin and myoglobin, are those 
that give the muscle its characteristic color depending on species (Gonzalez, 2015), 
although myoglobin is the main protein that determines color in meat and muscle.   
Myoglobin is only present in muscle and will receive oxygen from hemoglobin 
to store for the muscle to use in oxidative metabolism.  Myoglobin transports oxygen 
from the sarcolemma to the mitochondria (Wittenberg and Wittenberg, 1990), where 
oxygen will either receive carbon to make CO2 to be transported to the lungs, or act as 
the final electron receptor in the electron transport chain, which will be discussed later.  
Myoglobin also functions at the highest efficiency in the ferrous state. 
Myofibrillar proteins can be divided into three subcategories: regulatory, 
cytoskeletal, and contractile (Aberle et al., 2012).  Regulatory proteins include troponin 
and tropomyosin (Aberle et al., 2012).  There are three parts to troponin proteins; 
troponin C, troponin T, and troponin I.  Troponin C binds calcium, and calcium binding 
changes the shape of the entire troponin protein, shifting tropomyosin from blocking the 
actin-myosin binding site.  Troponin T physically binds to tropomyosin, so it is the 
protein that ultimately moves tropomyosin when calcium binds to troponin C.  Troponin 
I binds to actin, and inhibits myosin from binding to the actin-myosin binding site 
(Aberle et al., 2012; Cohen, 1975).  Two tropomyosin filaments are associated with each 
actin filament; each actin filament is made of two F-actin filaments (actin will be 
discussed later).  One tropomyosin molecule per F-actin molecule.  Tropomyosin 
molecules are made of two individual protein chains which form filaments, and two 
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filaments twist around each other to form an alpha helix.  Tropomyosin is what lies over 
the actin-myosin binding site and is the physical barrier that prevents myosin from 
binding to actin (Cohen, 1975). 
Cytoskeletal proteins are what provides the structure to the sarcomeres (Aberle et 
al., 2012).  Some of the major cytoskeletal proteins include C-proteins, titin, nebulin, 
desmin, skelemin, M-filament, α-actinin, and β-actinin.  C-proteins hold myosin 
molecules together by bundling myosin tails.  Titin is an important protein and the most 
abundant cytoskeletal protein (Aberle et al., 2012).  This protein connects myosin to the 
Z-disks and has a spring-like attachment to the Z-disk to allow for movement during 
contraction.  Nebulin is the second-most abundant cytoskeletal protein in muscle (Aberle 
et al., 2012) and anchors the thin filament (actin, troponin, and tropomyosin) to the Z-
disk, while α-actinin actually attaches the thin filament to the Z-disks.  Desmin connects 
the Z-disks of a sarcomere to adjacent sarcomere Z-disks.  M-filaments connect the M-
lines of adjacent sarcomeres together.  Finally, β-actinin caps the thin filaments, and 
regulates the length of actin in the sarcomere. 
The group of contractile proteins includes the major myofibrillar proteins (also 
called myofilaments), actin and myosin (Aberle et al., 2012).  These are the most 
important proteins in the skeletal muscle because of their role in muscle contraction.  In 
skeletal muscle, cells have the appearance of having stripes, which is termed striated.  
Striations occur because of the presence of sarcomeres, the subunits of myofibrils, which 
myofibrils are the tissue-specific organelles in muscle (Aberle et al., 2012).  Sarcomeres 
have two different colored regions, the A-band and the I-band.  The A-band is the darker 
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region and primarily contains overlapping myosin and actin filaments.  The I-band 
primarily contains actin filaments, which is why it is the lighter band. 
Structures called Z-disks form the boundaries of a sarcomere.  There are two Z-
disks per sarcomere, one at each end.  In the center of the two Z-disks is the M-line.  Z-
disks are pulled towards the M-line by the myofilaments during contraction.  
Myofilaments are referred to as thick (myosin) or thin (actin, troponin, tropomyosin) 
filaments (Aberle et al., 2012).  The M-line anchors the myosin proteins, which are 
oriented perpendicular to the M-line, and stretch on both sides of the M-line.  Myosin 
proteins are the workhorses of the sarcomere.  The myosin molecule is composed of a 
globular head, and a helical tail (Valin, Cross, and Smith, 1992).  The tails, which can be 
composed of light chains and heavy chains (Biletter et al., 1981), are held together by C-
proteins.  C-proteins act like a clamp to keep the multiple tail chains bound together. 
Proteins that compose thin filaments are actin, troponin, and tropomyosin.  Actin 
monomers are globules that are called G-actin, which can form filamentous chains called 
F-actin.  These polymers orient into double-stranded helices that connect to the Z-disks 
by the protein, nebulin.  Actin monomers contain a binding site where myosin can bind 
and pull the F-actin, and subsequently the Z-disks, towards the M-line during 
contraction.  Troponin complexes are positioned at regular intervals (every 7 G-actin) 
along actin filaments. 
The sarcolemma, or the plasma membrane of a muscle cell, surrounds the entire 
muscle fiber and invaginates into transverse tubules (t-tubules) that serve a purpose in 
electrical conduction during contraction.  An action potential travels across the 
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sarcolemma, which connects all of the muscle fibers in an entire muscle.  After nerve 
cells receive a stimulus from the brain and conduct the impulse along nerve cells, the 
action potential will eventually reach the sarcolemma.  Once the action potential travels 
through the t-tubules, the t-tubules eventually lead to longitudinal tubules, which is part 
of the same tube system as t-tubules.  These tubules conduct the action potential through 
the muscle ultrastructure and will reach the fenestrated collar.  The fenestrated collar lies 
over the terminal cisternae, which stores calcium.  The membranous system that includes 
the series of t-tubules and terminal cisternae that are involved in calcium sequestering is 
called the sarcoplasmic reticulum (SR) (Aberle et al., 2012).  The SR is similar to the 
endoplasmic reticulum in eukaryotic cells.  This organelle is made of membrane sacs 
and proteins that hold calcium in the SR to maintain homeostasis in the sarcomere.  Only 
an action potential can cause the release of calcium from the SR, which leads to 
contraction of the muscle. 
 
1.3 Muscle contraction 
At the beginning of each muscle contraction, an action potential begins the 
process.  A signal to the brain initiates a nerve impulse.  Neurons have a normal resting 
membrane potential of a negative intracellular charge, and a positive extracellular 
charge.  A nerve impulse opens sodium-potassium pumps, causing a net influx of 3 Na+ 
and a net efflux of 2 K+ ions, switching the charges of the cell membranes to a positive 
intracellular charge, and a negative extracellular charge.  This switching of membrane 
charges (the action potential) travels quickly from neuron to neuron until it reaches the 
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muscle cells.  The reason the action potential travels so quickly is because neurons are 
surrounded by a lipid membrane called myelin sheaths.  Impulse conduction speed is 
increased between 30 and 40-fold when the cells are myelinated (Aberle et al., 2012). 
Neurons specifically associated with muscles are called motor neurons.  After 
arriving at the muscle, the electrical charge stimulates the myoneural junction, which is 
the area that the dendrite of the motor neuron comes in close proximity to the muscle 
cell, but the two do not touch.  The space between the nerve and the muscle is called the 
synaptic cleft.  The electrical charge stimulates the dendrite of the motor neuron to 
release acetylcholine into the synaptic cleft. 
Acetylcholine is the chemical stimulus that converts the neural action potential 
into an action potential that the muscle is able to react to.  Acetylcholine binds to 
receptors on the sarcolemma, beginning the action potential in the muscle cell.  Similar 
to neurons, muscle fibers normally have a net negative intracellular charge and a net 
positive extracellular charge.  The acetylcholine switches the charges and causes an 
action potential in the muscle. 
As previously stated, the action potential will travel through the t-tubules and 
longitudinal tubules, to the fenestrated collar which overlies the SR.  A dihydropyridine 
receptor is embedded in the membrane of the t-tubule and is associated with a ryanodine 
receptor.  The ryanodine receptor connects directly with the SR.  When an action 
potential reaches the fenestrated collar, the action potential stimulates the 
dihydropyridine receptor, causing it to change shape and open.  When the 
dihydropyridine receptor changes shape, it stimulates the ryanodine receptor causing it 
8 
 
to change shape as well, subsequently stimulating the SR membrane to open.  Terminal 
cisternae will become permeable after being stimulated by the action potential, releasing 
calcium.  Calcium is released into the t-tubules and enters the ultrastructure of the 
sarcomere and binds to troponin.  Calcium alters the shape of troponin, causing the 
troponin to shift tropomyosin from the actin-myosin binding site. 
Regardless of the presence of ATP, myosin will bind to actin if the actin-myosin 
binding site is exposed and will produce a power stroke.  ATP is what breaks the bond 
between myosin and actin.  When ATP is present to break the bond between actin and 
myosin, the myosin heads will repeatedly attach and reattach, and pull the actin 
filaments, causing the Z-disks to move closer to the M-line. 
Once the muscle is in the contracted state, and impulses from the brain cease to 
stimulate contraction, steps to return to relaxation ensue.  Immediately after calcium is 
released from the sarcoplasmic reticulum, the calcium pump begins to sequester calcium 
back into the terminal cisternae of the sarcoplasmic reticulum.  The calcium pump uses 
ATP to re-sequester calcium back into the cisternae by using energy to pump against the 
established gradient.  Calcium enters back into the terminal cisternae of the SR, and 
proteins called calsequestrin bind calcium to hold it in the SR.  ATP breaks the bond 
between myosin and actin, allowing the Z-disks to slide back to resting state length.  
Calcium is released from Troponin C, causing tropomyosin to block the actin-myosin 
binding site.  Also, acetylcholinesterase reacts with acetylcholine, breaking this molecule 
down into acetate and choline to stop the action potential in the muscle. 
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1.4 Insulin function 
Insulin is a hormone that is important during digestion and energy utilization.  
This naturally-produced hormone increases the uptake of glucose into cells of peripheral 
tissues (Rhoades et al., 2007) allowing glucose to proceed through the glucose 
metabolism pathway, and be transformed into chemical energy in the form of ATP.  
Metabolism also increases deposition of energy reserves (glycogen). 
Cells take up glucose with the help of glucose transporter (GLUT) receptors.  
The type of receptor that cells in the body mainly use are GLUT4 receptors.  In the 
absences of insulin, GLUT4 receptors sit just inside the cell membrane.  When insulin 
binds to its respective receptor, a multi-step pathway eventually causes the GLUT 4 
receptors to travel to and fuse with the membrane, binding glucose and transporting it 
into the cell (Smith, 2017).  Other phenomena have to occur in order to “trap” glucose 
into the cell, which will be discussed later in this report.  Under normal feeding 
conditions (mostly pasture and forage diet), GLUT4 concentrations are highest in cattle 
at birth since they have a simple gastrointestinal system.  As cattle age and begin eating 
a diet higher in grass and hay, GLUT4 receptors decrease significantly, disallowing the 
ability to digest high concentrate diets. 
Insulin is produced in pancreas and is released by the Islet of Langerhans.  
Insulin is released when glucose concentrations are high in the blood.  Rhoades et al. 
(2007) showed that muscle and adipose tissue collected from steers converted a 
significant amount of glucose to CO2 and lactate after being treated with insulin, with 
muscle converting more glucose into CO2 and adipose tissue converting more glucose 
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into lactate depending on diet.  The difference in metabolic outputs means that glucose 
went through different cycles in the process of being oxidized to form chemical energy 
by the different tissues. 
Insulin increases lipogenesis and reduce lipolysis (Matsuzaki, Takizawa and 
Ogawa, 1997; Rhoades et al., 2007).  Rhoades et al. (2007) revealed subcutaneous 
adipose tissue in steers fed a corn diet had a higher in vitro rate of conversion of glucose 
to glyceride-fatty acid after being treated with insulin.  Had this experiment tracked 
tissue in an in vivo system, the result would have been hypertrophy of adipose tissue, 
specifically subcutaneous adipose tissue. 
However, blood-insulin concentrations tend to increase with age and body 
fatness in cattle (Matsuzaki et al., 1997; Rhoades et al., 2007; Schoonmaker et al., 2003; 
Trenkle and Topel, 1978) which can result in type II diabetes.  High insulin 
concentrations in the blood associated with insulin resistance can lead to an increase in 
blood-glucose concentrations after feeding (Schoonmaker et al., 2003) which is a normal 
physiological and metabolic response.  Insulin increases cell affinity to allow glucose to 
cross the membrane (with the help of glucose transporters) into the cell.  Once blood 
glucose levels drop to a homeostatic level, a metabolic signal will tell the body to 
decrease circulating insulin levels, causing insulin to be cleared from the system. 
High blood-insulin concentrations can also mean tissues are becoming insensitive 
to the hormone.  A consequence for decreased sensitivity would be a need for increased 
circulating levels of insulin to get the same effect after blood glucose levels spiked.  
Matsuzaki et al. (1997) revealed Japanese Black cattle had high blood insulin 
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concentrations, yet low blood glucose concentrations as body weight increased.  The diet 
these steers were fed was a normal high concentrate diet consistent with Japanese 
production conditions.  This type of increase in blood insulin levels is abnormal, and 
normally mean the cattle are in a poor state of health.  The increased plasma insulin 
levels in this study were associated with increased fatness in the steers, further 
reiterating the point that increased blood insulin levels are associated with obesity. 
 
1.5 Glucose metabolism 
When free glucose circulates in the blood, glucose is available to be utilized by 
body tissues.  There are a few pathways that comprise glucose metabolism.  These are 
glycolysis, the tricarboxylic acid cycle (TCA), glycogen metabolism, and the electron 
transport chain (ETC). 
 
1.5.1 Glycolysis 
During growth and development, or muscle contraction, chemical energy is 
required in order to be able to attain these outcomes.  Energy in the form of ATP can be 
formed via glucose metabolism by way of glycolysis, glycogen metabolism, and 
gluconeogenesis.  Glycolysis begins by glucose entering the cell due to the presence of 
insulin, which increases glucose uptake in the cell (Freedland and Briggs, 1977).  Once 
in the cell, glucose is converted to glucose-6-phosphate (G6P) by hexokinase to keep the 
molecule in the cell.  This traps glucose in the cell and begins the process of committing 
glucose to subsequent metabolism.  After phosphoglucose isomerase converts G6P to 
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fructose-6-phosphate (F6P), 6-phosphofructokinase (6-PFK) will convert F6P into 
fructose 1-6 bisphosphate (F-1, 6-P2).  At this point, glucose is now “trapped” in 
glycolysis, and has to complete the glycolytic pathway.  Glucose will eventually be 
transformed into the final product, pyruvate (Freedland and Briggs, 1977).  Not only 
does glycolysis produce pyruvate, it also produces NADH and 2 ATP. 
Pyruvate can be converted to lactate, which will travel to the liver via the 
bloodstream, and will be re-converted into glucose by gluconeogenesis. 
 
1.5.2 Glycogen metabolism 
Another pathway glucose can follow is glycogen metabolism.  During glycogen 
synthesis, after G6P is produced during glycolysis, phosphoglucomutase transfers the 
phosphate group to the 1-carbon, producing glucose-1-phosphate (G1P).  Combining 
with uracil-triphosphate (UTP), G1P uridyltransferase converts G1P and UTP into UDP-
glucose plus two inorganic phosphates (Freedland and Briggs, 1977).  The glucose 
residues, called glucosyl units, are attached to the non-reducing end of a glycogen 
molecule that is already stored in the body, by way of glycogen synthase.  When 
glycogen synthase is activated, this enzyme attaches glucosyl residues at the reducing 
end of glycogen branches, storing excess energy in case of emergency situations.  
Glycogen synthase, like any other enzyme, can be regulated.  There are three places on 
each glycogen synthase molecule that a phosphate group can bind to.  When there are no 
phosphate groups attached to glycogen synthase, the enzyme is active.  When a 
phosphate group is bound to all of the binding sites on glycogen synthase, the molecule 
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is inactive.  Varying levels of activity are possible depending on how many phosphate 
groups are bound to glycogen synthase as well. 
During glycogen degradation, glycogen phosphorylase is activated through a 
series of phosphorylation steps.  Protein kinase A (PKA) phosphorylates phosphorylase 
kinase, which in turn phosphorylates glycogen phosphorylase (active form).  Activated 
glycogen phosphorylase releases glycosyl residues from glycogen stores at α- 1-4 
linkages, producing G1P by adding a phosphate group to the 1- carbon as well as α- 1-6 
branch points, the latter producing free glucose.  Glucose-1-phosphate can be converted 
into G6P to be used in glycolysis. 
 
1.5.3 Tricarboxylic acid cycle 
Not only can PEP go into gluconeogenesis, it can also enter the tricarboxylic acid 
cycle (TCA) after being turned into pyruvate.  The TCA cycle begins by pyruvate 
reacting with a Coenzyme A (CoA) and an NAD+ molecule, forming acetyl Coenzyme A 
(acetyl CoA).  Two metabolites produced from this reaction are a CO2 and NADH 
molecule.  Acetyl CoA combines with OAA, a 4-C molecule, to form Citrate, a 6-C 
molecule.  An H+ molecule is formed as well.  Citrate is turned into Isocitrate with the 
help of the enzyme, Aconitase.  Isocitrate is turned into α-ketoglutarate by way of the 
enzyme Isocitrate dehydrogenase.  From this reaction, a CO2 and an NADH molecule is 
formed. 
Succinyl CoA is formed from α-ketoglutarate dehydrogenase removing a 
carboxyl group from α-ketoglutarate.  A CO2 and an NADH molecule are formed from 
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this reaction.  Succinyl CoA is transformed into Succinate by the enzyme Succinyl CoA 
synthetase, and Succinate is turned into Fumarate by the action of Succinate 
dehydrogenase.  An FADH2 molecule is formed from this reaction.  Fumarate is turned 
into Malate from the interaction of fumarate hydratase and H2O.  Finally, Malate is 
transformed into OAA by the action of Malate dehydrogenase.  An NADH molecule and 
an H+ is formed from that reaction.  In total, the metabolites from the TCA cycle are 4 
NAHD, 3 CO2, 2 H+, and 1 ATP (Hardin, Bertoni, and Kleinsmith, 2015). 
 
1.5.4 Electron transport chain 
After NADH and FADH2 are produced from the TCA cycle, these are 
transported to the folds in the mitochondria.  The folds are called cristae: this is where 
the electron transport chain (ETC) is located.  NADH and FADH2 donate their H+ ions 
which exit the mitochondrial matrix, forming a gradient so ATP synthase can pull H+ 
ions into the mitochondria matrix.  This established gradient allows ATP synthase to 
produce ATP for the cell for energy usage.  Once NADH and FADH2 are turned into 
NAD+ and FAD, respectively.  H+ ions will exit the mitochondria, causing a gradient to 
form.  The established gradient will activate the proton pump that is embedded in the 
mitochondrial membrane.  H+ ions that have accumulated outside of the mitochondrial 
membrane are pumped into the cell, causing ADP to be turned into ATP.  One molecule 
of glucose will form 34-36 molecules of ATP by way of the ETC (Hardin et al., 2015). 
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1.6 Introduction to β-AA 
As previously stated, excessively obese cattle are being produced, which is 
causing a decrease in the amount of edible product being produced.  Ricks et al. (1984) 
reported that β-AA would decrease the amount of fat accumulation in livestock species.  
β-AA are in a class of pharmaceutical drugs called phenethanolamines (Anderson et al., 
2004; Scramlin et al., 2010).  As previously mentioned, these chemicals repartition 
energy from adipose tissue accretion to muscle growth; which is why Ricks et al. (1984) 
coined the term “repartitioning agent” for β-AA. 
Phenethanolamine drugs are laboratory produced chemicals.  Some of the better 
known phenothanolamines are zilpaterol hydrochloride (ZH), clenbuterol, salbutamol, 
and ractopamine hydrocholoride.  Some similarities between the structures of these two 
classifications of chemicals are, they all have at least one carbon ring, and an amine 
group.  Compounds such as ractopamine hydrochloride and ZH are used in livestock 
production to increase lean muscle mass, and decrease excess subcutaneous and internal 
adipose tissue accretion.  β-AA are also classified as sympathomimetic drugs when 
related to human medical use (Spratto and Woods, 2003).  Uses of β-AA in the human 
medical industry include controlling contraction of the heart, increase lipolysis, stimulate 
vasodilation of the extremities, and control symptoms of certain diseases such as asthma 
and chronic obstructive pulmonary disorder (COPD). 
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1.7 Introduction to catecholamines 
β-AA are chemically and structurally similar to the naturally occurring 
catecholamines (Bell et al., 1998).  Catecholamines are a group of hormones that include 
norepinephrine, epinephrine, and dopamine.  The name catecholamine was given to this 
group because of their common catechol group, which is a carbon ring with two 
hydroxyl groups projecting from the 2nd and 3rd carbon.  Catecholamines and 
phenethenolamines are similar in structure due to the presence of at least one carbon 
ring, and an amine group.  Epinephrine and norepinephrine are associated with the “fight 
or flight” response; also called the stress response.  The main effects of this response are 
an increase in respiratory and circulatory rates, and a decrease in glycogen stores.  These 
two hormones also increase during physically demanding situations, such as exercise. 
Dimsdale and Moss (1980) showed the increase in epinephrine and 
norepinephrine levels in the systems of medical physicians during different tasks that 
they would complete on the job.  During exercise (walking up flights of stairs), both 
hormones increased but norepinephrine almost tripled during exercise.  During the first 
three minutes of a speech at a conference, both epinephrine and norepinephrine doubled 
to tripled from the baseline levels of these hormones.  Clearly these two hormones are 
expressed in the greatest amounts during situations that induce stress. 
Once the stress state is reached, and these hormones are released, different 
metabolic events occur.  Blood circulation increases after the heart muscles are 
stimulated (Kaumann et al., 1999), increasing blood flow through the vessels, resulting 
in more nutrient rich blood that arrives to muscle and adipose tissue.  Epinephrine and 
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norepinephrine will also increase the breakdown of glycogen and fatty acids 
(Cunningham and Friend, 1965) which can be utilized by the body as emergency energy. 
After injecting 0.25 mg/80kg of epinephrine into pigs, Cunningham and Friend 
(1965) reported their pigs came off of their feed.  After an epinephrine injection, blood-
glucose levels had reached a point to where their pigs were receiving a signal from the 
brain that they were full.  The injected epinephrine had broken down glycogen stores 
into glucose, and released into the blood stream.  Similar results were reported for cattle, 
in that epinephrine injection significantly reduced muscle glycogen (Crouse and Smith, 
1986).  Body tissues could then utilize the free glucose for growth or energy production.  
Free fatty acid levels in the blood of these pigs acted similar to glucose, with the levels 
increasing a few hours after an epinephrine injection (Cunningham and Friend, 1965).  
Triacylglycerol was mobilized by epinephrine and formed free fatty acids that could 
have been used as a source of energy as well.   
Epinephrine has an effect on both glycogen and fat stores.  Norepinephrine 
behaved in a similar manner, although norepinephrine worked to a greater extent on fat 
stores than glycogen stores.  Norepinephrine had about a 300% greater impact on free 
fatty acid levels in the blood compared to epinephrine (Cunningham and Friend, 1965).  
Thus, epinephrine and norepinephrine are catabolic hormones since clear evidence was 
presented that glycogen was broken degraded, and triacylglycerols were mobilized into 
blood metabolites (Cunningham and Friend, 1965). 
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1.8 β-AA receptors 
β-AR are embedded in the membranes of muscle and adipocytes.  Each β-AR has 
seven transmembrane domains, and three extracellular loops and three intracellular loops 
(Johnson, Smith and Chung, 2014; Mersmann, 1998).  The extracellular end of the 
receptor contains an N-terminus, which is normally associated with stimulation of the 
receptor, while the intracellular end contains a C-terminus, which is normally associated 
with inhibition of the receptor (Johnson et al., 2014; Mersmann, 1998).  Mersmann 
(1998) reported that β-AR interact with a GS protein in the proximity of intracellular loop 
2, 3, and 4.  Recently, that location was isolated to loop 3 (Johnson et al., 2014).  Each 
GS protein is associated with adenylate cyclase.  Also, a ligand binding site (the site 
where the β-AA would bind to the receptor) is associated with transmembrane domains 
3, 4, 5, and 6. 
There are three β-AR subtypes; β1, β2, and β3.  β1-AA receptors are typically 
embedded in slow twitch, or Type I and Type IIA muscles, while β2-AR are associated 
with fast twitch, or Type IIB and Type IIX muscles.  Kim et al. (1987) concluded type II 
fibers are more sensitive to β2-AA.  Also, Sillence et al. (1991) and Sillence and 
Matthews (1994) reported in their two separate studies that β1-AR were not detectable on 
certain bovine muscles.  These findings agree with the study conducted by Miller et al. 
(1988) which determined through histochemical testing that type II fibers increased in 
size via hypertrophy, while type I fiber size decreased significantly.  Therefore, β-AA 
should increase the amount of edible muscle in livestock species. 
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1.8.1 β3-AA receptors 
Prior to the 1970’s, the only two receptor subtypes that were known to be present 
in animal tissues were the β1, and β2-AR.  These two receptor subtypes were thought to 
predominantly be embedded in muscle cell walls.  The β3-AR were not discovered until 
the beginning of the 1970’s (Mersmann, 1998).  These receptor subtypes were first 
discovered embedded in brown and white adipose tissue in rats.  There was a possibility 
that β3-AR could be present in skeletal muscle and cardiac muscle (Mersmann, 1998).  
Up until 2012, the status quo remained that β3-AR were only present in the two different 
adipose tissue types. 
Miller et al. (2012) extracted mRNA from semimembranosus muscles from cattle 
treated with different concentrations of ZH.  Graphs from this study revealed that the 
treated muscle was composed of β1-, β2-, and β3-AR.  Before this study, there was no 
previous evidence of β3-AR being present in the membrane of skeletal muscle.  
However, these scientists graphed the amount of β-AR relative to the β-AA receptors in 
the control, so the abundance of the β3-AR embedded in the semimembranosus muscles 
were not determined. 
 
1.9 β-AA mechanisms 
β-AA work in the same manner as epinephrine and norepinephrine.  The specific 
series of metabolic events begins when a β-AA binds to a β-AR.  The GS protein directly 
interacts with adenylate cyclase (Anderson et al., 2004; Johnson et al., 2014) after being 
activated by a β-AR.  Adenylate cyclase activation causes a series of phosphorylation 
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events ultimately leading to the activation of phosphorylase kinase.  This causes the 
repartitioning of energy from adipose tissue accretion to muscle growth. 
Binding of a β-AA to a receptor changes metabolic pathways and signals, 
causing a cascade of events that alter glucose, muscle, and fat metabolism towards 
muscle accretion (Anderson et al., 2004).  Immediately after a β-AA binds to a receptor, 
the GS protein interacts with, and simultaneously activates adenylate cyclase, converting 
adenosine triphosphate (ATP) into cyclic adenosine monophosphate (cAMP).  Many 
metabolic events are controlled by the presence of cAMP (Smith, 1987). 
There are four binding sites on the regulatory protein that controls the activity of 
PKA.  Increasing cAMP concentrations cause enough of this intracellular metabolite to 
bind to the regulatory protein.  Once all four places are bound, the regulatory protein will 
release PKA, activating it (not phosphorylating it).  PKA phosphorylates, and 
simultaneously activates phosphorylase kinase.  Subsequently, increasing cAMP 
concentrations inhibit glycogen synthase, causing phosphate groups to become bound to 
the binding sites, and ultimately inhibiting the functionality of this enzyme. 
 
1.9.1 β-AA mechanisms on glucose metabolism 
There are three functions of phosphorylase kinase during glycogen metabolism.  
The first is to phosphorylate a specific region of glycogen synthase, decreasing the 
activity of glycogen synthase slightly.  Glycogen synthase has three regions that can be 
phosphorylated.  One site is phosphorylated by glycogen phosphorylase, as previously 
stated.  Another site is bound by a cAMP-dependent kinase, and the third by a glycogen 
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synthase-dependent kinase.  If all sites are bound by phosphate, glycogen synthase will 
become inactivated.  The function of active glycogen synthase is to add glucosyl 
residues to stored glycogen chains to the non-reducing end of the glycogen chain.  This 
function will cease when a β-AA binds a receptor, disallowing glycogen synthesis. 
The second function of phosphorylase kinase is to activate glycogen 
phosphorylase.  After glycogen synthase is deactivated, glycogen phosphorylase will 
break glucosyl residues from the non-reducing end of the α-1, 6 branch points on stored 
glycogen.  The third function of phosphorylase kinase is to add a phosphate group to 
these free glucosyl residues.  The phosphate group will be added to the 1-carbon, 
creating G1P.  Phosphoglucomutase will transfer the phosphate group from the 1-carbon 
to the 6-carbon, producing G6P.  Once G6P is formed, the normal glycolysis cycle can 
ensue to utilize chemical energy. 
 
1.9.2 β-AA mechanism on insulin sensitivity 
Traditionally, β-AA are known to decrease carcass fatness in steers after being 
fed during the finishing phase.  In rats treated with one dose of 10 µg/kg compared to a 
saline injection, glucose utilization index for specified muscles doubled on average in 
treated rats (Liu and Stock, 1995).  In this experiment, the glucose utilization index 
indicated that glucose was being taken up into the muscles, meaning the β-AA in this 
experiment caused insulin sensitivity to increase (caused an insulin response).  Liu and 
Stock (1995) also revealed in their study, treated rats produced a significant, 2.5 fold 
increase in plasma insulin.  One effect of β-AA action on muscle tissue, as previously 
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mentioned, is the breakdown of glycogen stores into glucose residues, ultimately 
increasing blood glucose levels.  Excess glucose in the blood signals the pancreas to 
release insulin into the blood.  These data agree with the metabolic events caused by β-
AA. 
 
1.9.3 β-AA mechanisms on muscle tissue 
As previously stated, β-AA redirect chemical energy from accretion of fat muscle 
growth.  Muscle mass is thought to be increased in livestock by decreasing protein 
degradation, and increasing protein synthesis (Johnson et al., 2014).  Ergo, the body is 
decreasing protein turnover to increase leanness and mass.  Muscle response to β-AA 
begins when a β-AR is activated and cAMP is produced (Mersmann, 1998).  Muscle 
mass increases via hypertrophy of muscle fibers (Anderson et al., 1991; Beermann, 
2002; Johnson et al., 2014; Mersmann, 1998; Smith, 1987).  Specifically hypertrophy of 
type II muscle fibers (Beermann, 2002; Johnson et al., 2014; Mersmann, 1998; Smith, 
1987). 
Schiavetta et al. (1990) proposed in their study that muscle hypertrophy was 
induced by an increase in protein synthesis, or a decrease in proteolysis.  Both protein 
synthesis and protein degradation occurring simultaneously (Smith et al., 1995; 
Mersmann, 1998; Wheeler and Koohmaraie, 1992) has been the suggested mechanism of 
β-AA function on muscle metabolism as well.  Protein synthesis in animals treated with 
β-AA was induced by an increase in protein transcription, leading to mRNA production 
(Hod, Morris, and Hanson, 1984; Smith et al., 1989). Myofibrillar mRNA specifically 
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(Anderson et al., 1991; Hod et al., 1984; Smith et al., 1989) provides a template for new 
muscle fibers to be formed and would likely be a result of β-AA induced up-regulation 
of myofibrillar protein gene transcription (Smith, Garcia and Anderson, 1989; Smith et 
al., 1995).  Accumulation of protein mRNA would lead to an increase in protein 
synthesis and accretion, causing muscle hypertrophy. 
The implication that muscle grows via hypertrophy is because of the observation 
that there was not a change in the amount of DNA produced resulting from feeding cattle 
different concentrations of ZH (Miller et al., 2012).  Muscle hypertrophy can occur only 
if there is a repartitioning of nutrients away from adipose tissue.  After β-AR are 
stimulated, increasing cAMP concentrations inhibit lipogenic enzymes, and stimulate 
lipolysis enzymes, causing adipose tissue degradation via lipolysis, releasing free fatty 
acids into the blood.  These fatty acids will then be used as an alternative source of 
energy for amino acid production (Ricks et al., 1984) if the need arises in the animal. 
As previously stated, β-AA are chemically related to catecholamines, which can 
elicit a “fight or flight” response.  β-AA increase circulation of blood in the same 
manner as catecholamines.  As glycogen and adipose tissue stores are catabolized, 
nutrient concentrations increase in the blood.  A simultaneous increase in circulation and 
respiration occurs as well.  A higher circulation rate causes more nutrient-rich blood to 
flow to the muscles after treatment with β-AA (Smith, 1987).  Not only will this increase 
chemical energy flow to muscles, studies show that specific nutrients that become more 
readily available to cattle, including nitrogen uptake (Smith, 1987) and retention in the 
hindlimbs of cattle.  Nitrogen is an essential building block for amino acids, which go on 
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to produce proteins.  Increased nitrogen accumulation near growing muscles would 
increase amino acids available for protein accretion. 
An increase in muscle mass and size is be a consequence of decreased protein 
catabolism.  Ricks et al. (1984) proposed that β-AA caused muscle hypertrophy as a 
result of decreased protein degradation.  Myofibrillar proteins can become damaged or 
too old to function during the normal turnover cycle, and need to be replaced.  Calpains 
are molecules located in muscle tissues that function in protein degradation. 
Cessation of protein degradation is thought to occur by inhibiting calpains 
through an increase in calpastatin concentration (Wheeler and Koohmaraie, 1992; 
Sensky et al., 1996; Killefer and Koohmaraie, 1994).  Wheeler and Koohmaraie (1992) 
and Killefer and Koohmaraie (1994) reported that a β2-AA reduced protein degradation 
in steers, and that calpastatin was elevated in these steers as well.  During the normal 
aging period of livestock carcasses, calpains break down the Z-disks of the sarcomeres.  
calpastatin decreases Z-disk degradation by inhibiting calpain activity.  Data suggest in 
pigs infused with epinephrine, an increase in calpastatin concentration was exhibited 
(Sensky et al., 1996) as well. 
 
1.9.4 β-AA mechanism on adipose tissue 
Because energy production is redirected to muscle production, this means 
adipose tissue production is decreased in livestock fed β-AA.  As previously described, 
in the early stages of the metabolic pathway during glucose uptake, adenylate cyclase 
activation (due to interaction with the GS protein) increases cAMP production.  Protein 
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kinase A is activated after four cAMP molecules bind to the regulatory protein that 
keeps PKA activity dormant.  Protein kinase A not only activate phosphorylase kinase, 
but it can also activate lipase and deactivate lipogenic enzymes (Anderson et al., 1991).  
Thornton et al. (1985) tended to agree with these statements, revealing in their study a 
distinct decrease of lipogenesis and a three-fold increase in lipolysis rate as the level of 
clenbuterol increased from 0 to 0.1 µg, and an even larger increase in lipolysis after 
increasing clenbuterol concentrations from 0.1 to 10 µg.  With such a drastic change in 
lipid metabolism, there is no surprise when studies revealed these metabolic events cause 
significant decreases in marbling scores (Miller et al., 1988; Miller et al., 1989) and in 
external fat cover (Miller et al., 1988; Miller et al., 1989; Ricks et al., 1984; Thornton et 
al., 1985). 
 
1.10 Radioactive material in in vitro experiments 
In most experiments that study in vitro metabolism of muscle tissue, the element 
that is used is 14C.  This is a radioactive element that can be manually incorporated into 
glucose metabolism during the incubation periods of these experiments.  Radiolabeled 
elements, known as tracers, make it possible to conduct metabolism and biochemistry-
based experiments.  The common elements used are 3H, 14C, 32P, and 35S.  These 
elements are called radioisotopes.  In the current study, 14C is the radioisotope used 
because of ease of incorporation into metabolites produced during glucose metabolism in 
adipose tissue and muscle. 
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14C is an unstable isotope of the stable form of carbon, which is 12C.  The 
instability is useful when a liquid scintillation counter is utilized.  14C degrades after one 
neutron converts to a proton, changing the chemical identity of the element.  Nitrogen 
and a radioactive electron are produced after 14C disintegrates. 
The unit used in metabolism studies is the µCi.  A Curie (Ci) is the base unit 
when measuring radioactive elements (similar to the gram or the meter).  One Ci is equal 
to 2.22 X 1012 dpm, meaning in one minute, 2.22 X 1012 radioactive degradations occur, 
such as the example of 14C degrading into Nitrogen and one electron.  In most 
laboratories, the µCi is what is used, which is equal to 2.22 x 106 dpm. 
14C acts well as a tag during metabolism studies.  Only a small amount of the 
radiolabeled element is added (1 µCi) to media, therefore a ratio can be determined of 
radiolabeled glucose to unlabeled glucose.  This ratio is multiplied to dpm picked up by 
a scintillation counter to give a   Depending on which metabolite is tested for the tag 
(i.e., glycogen, and CO2), measured dpm can be multiplied by a certain number to get 
the amount of carbon incorporated into the metabolites.  For example, if the scintillation 
counter detects 99.47 dpm from a glycogen sample from an in vitro experiment, that 
number will be multiplied by 6, since there are 6 carbons to a glucose carbon ring, and 
only one of those carbons are tagged with the µCi of glucose. 
Scintillation liquid that the electrons (β-particle) are dissolved in help to 
enumerate disintegrations of 14C to detect metabolites.  Suspended in the scintillation 
liquid are molecules that can fluoresce, called fluors, due to electrical excitation after 
interacting with β-particles.  β-particles become surrounded by the fluors after being 
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mixed with the scintillation liquid.  Electrical energy is passed to the fluors after 
disintegration, and excites the fluors, causing them to fluoresce and give off light.  
Scintillation counters detect the light with the help of a photomultiplier, which can be 
translated into a numeric count of radioactive 14C as disintegrations per minute (dpm). 
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CHAPTER II 
MATERIALS AND METHODS 
 
2.1 Animals and facilities 
Four Angus or Angus-cross steers (with no Brahman influence) were used in this 
study.  All steers were fed a finishing diet at the Texas A&M University Research 
Center at McGregor, TX.  Steers were transported to the Texas A&M Beef Center within 
the O. D. Butler Jr. Animal Science Center, located in College Station, TX until muscle 
samples were ready to be collected.  When muscle samples were collected, they were 
prepared for in vitro metabolism analysis in the adipose tissue and muscle tissue 
laboratory, located within the Kleberg Animal & Food Sciences Center at Texas A&M 
University in College Station, TX.  These cattle were harvested under the AUP AACUC 
#2016-009A.  Tissue samples used in this study were obtained through tissue sharing 
from cattle under this same AUP. 
 
2.2 Harvest procedures, sample collection, and sample preparation 
On scheduled slaughter days, each steer was haltered and restrained, exposing the 
right jugular vein.  All animals were stunned using a captive bolt stunner and were tested 
for reflexes of the eye and nose before exsanguination.  The right jugular vein was 
severed to exsanguinate each steer.  Immediately after exsanguination, the LL muscle on 
the right side of each animal, stretching from approximately the 9th to 11th rib was 
removed from each carcass for muscle samples. 
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LL muscles were transported to the laboratory by being placed in a container 
with media consisting of KHB (pH 7.4) and 5 mM glucose, warmed to 37°C.  These are 
similar transporting methods used by Coleman, Eckeren, and Smith (1988), Espinal, 
Dohm, and Newsholme (1983), Miller et al. (1989), and Schiavetta et al. (1990), with 
the latter methods being adapted from Prior and Jacobson (1979).  Once at the 
laboratory, LL samples were cut into sections, and from the sections, muscle strips were 
cut using sterile scalpels and forceps.  The muscle strips were between 100-300 mg, and 
ran parallel to the muscle fiber orientation. 
 
2.3 Experimental design 
Muscle strips were placed in individual flasks for analysis of metabolism.  Flasks 
were placed in the shaking water bath.  Each flask contained 3 mL of KHB, 5 mM 
glucose, a single muscle strip, and 1µCi [U-14C]glucose.  Each flask was capped with a 
rubber stopper, perforated to hold a hanging center well.  A folded piece of filter paper 
was placed in each hanging center well, and each piece filter paper saturated with 2 N 
NaOH.  All flasks were subjected to a 90 min incubation period in the water bath. 
 
2.3.1 Experiment one and two 
For experiment one, 45 muscle strip samples were used.  Three treatment groups 
made up this experiment; a Control group, a group containing Experior (Elanco Animal 
Health, Greenfield, IN), and a group containing BRL 37344 (Tocris Bioscience, Bristol, 
UK).  Five different insulin concentrations (0, 10-9, 10-8, 10-7, and 10-6 M) were tested in 
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triplicate (this makes the three groups of 15 for a total of 45 samples).  These treatment 
groups directly tested for a β3-AA receptor response in the muscle strips.  The Control 
group flasks contained only 5 mM glucose, 1µCi [U-14C]glucose in Krebs-Hensleit 
buffer (pH 7.35-7.4), one muscle strip, and insulin (either 0, 10-9, 10-8, 10-7, or 10-6 M).  
The second treatment group contained all of the materials named in the Control group, 
plus 50 µM Experior.  The third set of flasks contained all of the materials specified for 
the Control group, plus 50 µM BRL 37344. 
 
2.3.2 Experiment three 
Thirty-six muscle strip samples were used in this experiment.  There were two 
treatment groups: a Control group and a group that contained Experior.  Six different 
insulin concentrations (0, 10-9, 10-8, 10-7, 10-6, and 10-5 M) were tested in triplicate (this 
makes up the two groups of 18, for a total of 36 samples).  Each flask in the control 
group contained one concentration of insulin, 5mM glucose, 1 µCi [U-14C]glucose, 3 mL 
KHB, and one muscle strip.  The treatment group included all materials specified in the 
Control group, plus 50 µM Experior. 
 
2.3.3 Experiment four 
Fifty-four samples were used in this experiment.  This experiment tested three 
incubation times: 30, 60, and 90 min.  Six different concentrations of insulin (either 0, 
10-9, 10-8, 10-7, 10-6, or 10-5 M) were tested in triplicate (this makes up the three groups 
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of 18, totaling 54 samples).  Each flask in this experiment contained one concentration 
of insulin, 5mM glucose, 1 µCi [U-14C]glucose, 3 mL KHB, and one muscle strip. 
 
2.3.4 Muscle CO2 synthesis 
After the initial incubation time was complete, 0.5 mL 2 N H2SO4 was injected 
into the flasks to stop metabolic reactions.  Muscle strips were not placed back into the 
flasks once the H2SO4 was injected so as to not interfere with enzyme activity in the 
muscle strip.  The flasks containing the media and injected with H2SO4 was subjected to 
another 60 min incubation period in the shaking water bath so CO2 could react with the 
NaOH, forming NaHCO3 which represents CO2 produced during glucose metabolism 
from the muscle strips.  Once the second incubation period was complete, the filter paper 
was placed into individual scintillation vials, followed by an addition of 1 mL of water 
and 10 mL of scintillation cocktail.  The recovery of 14C-labeled glucose carbon in 
glucose was measured by a Beckman L53000 liquid scintillation counter. 
 
2.3.5 Muscle glycogen synthesis 
Alternatively to being placed back into the flasks, muscle strips were placed in 
glass test tubes containing media to obtain weights for glycogen, lactate, and CO2 
radiolabeled carbon calculations.  Muscle strips were transferred to individual 15-mL 
screwcap test tubes and kept at 4°C when chemical analyses were not being performed.  
Muscle strips were rinsed with 0.5 mL of water, and 3 mL of 75% ethanol, and vortexed 
to dilute the [U-14C]glucose.  This process was repeated three times.  The mixture caused 
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the coagulation of glycogen synthesized during the initial incubation period.  The 
coagulated glycogen is called a glycogen pellet.  After the third dilution series, pellets 
sat overnight, and glycogen pellet were transferred to individual scintillation vials.  Each 
pellet was mixed with 1 mL of distilled water, and 10 mL of scintillation cocktail.  Each 
vial was gently swirled in order to dissolve each pellet.  The recovery of 14C-labeled 
glucose carbon in glucose was measured in a liquid scintillation counter. 
 
2.3.6 Muscle lactate synthesis 
After the initial 90 min, and the additional 60 min incubation period were 
completed, media from each flask was transferred to individual 15 mL screw cap test 
tubes.  Lactate Assay Kits were purchased from Eton Bioscience (Eton Bioscience, Inc., 
San Diego, CA) and utilized to determine lactate production from the metabolism of 
muscle strips.  A standard curve was established in order to calculate lactate production.  
The standard curve was determined by mixing 50, 40, 30, 20, 10, 5, 1, and 0 µL of L-
lactate Standard with double distilled water to produce a total volume of 50 µL in each 
well that holds the standard curve media. 
Media from the flasks had to be neutralized (pH of 7.4-8) in order for the lactate 
assay solutions to work.  50 µL of media from each screw cap test tube were placed in 
individual wells.  Media was tested in duplicate.  Fifty µL of L-Lactate Assay Solution 
was added to each well containing media to initiate the reaction.  Plates were wrapped in 
aluminum foil and incubated at 37°C for 30 min.  After the incubation period was 
complete, 50 µL of 0.5 M acetic acid was added to each well containing media stop the 
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reaction.  The well plates were gently agitated for 20 sec.  Absorbance was measured at 
490 nm using a BioTek Epoch 96-well plate reader. 
 
2.4 Statistical analysis 
Data were analyzed as a two-way analysis of variance (SuperANOVA®: Abacus 
Concepts, Inc., Berkeley, CA).  Main effects were treatment (insulin, Experior, and ß3-
AA); the model also tested theinsulin x Experior or ß3-AA interaction.  Main effects and 
interactions were considered significant at (P < 0.05).  
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CHAPTER III 
RESULTS 
 
A preliminary experiment was conducted to determine the effect of incubation 
time (30 min, 60 min, 90 min) on insulin sensitivity; glycogen, CO2, and lactate 
production was linear over time.  Experiments were conducted to measure to conversion 
of glucose to glycogen, CO2, and lactate in muscle strips incubated with either 50 µM 
Experior, 50 µM BRL 37344, or no β-AA (Control).  All flasks contained increasing 
amounts of insulin to specifically test the interaction between insulin and ß3-adrenergic 
agonists (ß3-AR). 
For glucose conversion to glycogen, there was a significant treatment effect (P < 
0.001) (Figure 1).  BRL 37344 caused lower levels of glucose conversion to glycogen 
than either the Control or Experior.  BRL 37344 caused 62% lower amounts of glycogen 
synthesis compared to the Control samples (insulin only), and produced 50% lower 
amounts of glycogen synthesis compared to Experior samples.  The Control samples 
produced the highest amount of glycogen (4.3 nmol/100 mg·90 min), while Experior 
produced an intermediate amount of glycogen (3.1 nmol/100 mg·90 min), between 
Control and BRL 37344 (1.6 nmol/100 mg·90 min).  Experior did not have a consistent 
effect on glycogen production as insulin concentrations changed. 
There was a significant treatment effect for CO2 production (P = 0.018; Figure 2 
and Table 1).  BRL 37344 caused the highest amount of glucose conversion to CO2 
compared with the other treatments.  BRL 37344 elicited 23% more glucose conversion 
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to CO2 than Experior, and 41% more CO2 than Control samples.  The Control samples 
produced the lowest amount of CO2 (171.3 nmol/100 mg·90 min), whereas Experior 
produced an intermediate amount of CO2 (222.9 nmol/100 mg·90 min) between the 
Control and BRL 37344 (292.6 nmol/100 mg·90 min).  There was not a significant main 
effect of treatment on lactate production (P = 0.419; Figure 2 and Table 1). 
The insulin x treatment interactions were not significant glycogen (P = 0.221; 
Figure 3), CO2 (P = 0.641; Figure 4), or lactate (P = 0.748; Figure 5).  There was not a 
significant main effect of insulin concentration on glycogen production (P = 0.634), CO2 
production (P = 0.953), or lactate production (P = 0.953). 
 
 
 
Table 1. Main effects means for the conversion of glucose to glycogen, CO2, and lactate in vitro. 
 
 Treatment  
Metabolite Insulin Experior ß3-AA Pooled SEM P-values 
Glycogen 4.3a 3.1b 1.6c 0.3 0.001 
CO2 171.3b 222.9ab 292.6a 23.5 0.018 
Lactate 638.5 622.3 640.1 40.4 0.419 
Units are nmol/(100 mg·90 min) 
abcMeans with common superscripts are not different (P > 0.05). 
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Fig 1: Glucose conversion to glycogen (nmol/100 mg·90 min) between treatment groups. 
abcMeans with common superscripts are not different (P > 0.05) 
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Fig 2: Glucose conversion to lactate and CO2 nmol/100 mg·90min between treatment groups. 
abcMeans with common superscripts are not different (P > 0.05) 
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Fig 3: Insulin x treatment interaction graph for glucose conversion to glycogen (nmol/100 
mg·90min). n = 3.  The insulin x treatment interaction was not significant (P = 0.221) 
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Fig 4: Insulin x treatment interaction graph for glucose conversion to CO2 (nmol/100 
mg·90min). n = 3.  The insulin x treatment interaction was not significant (P = 0.641).  
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Fig 5: Insulin x treatment interaction graph for glucose conversion to lactate (nmol/100 
mg·90min). n = 3.  The insulin x treatment interaction was not significant (P = 0.748) 
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CHAPTER IV 
DISCUSSION 
 
The most important finding from this study is that muscle strips reacted to BRL 
37344 in a manner that supported our hypothesis that muscle does contain β3-AR.  These 
results refute the accepted theory that β3-AR are present only on brown and white 
adipose tissue membranes. 
Stimulation of β-AR increases glycolysis and strongly depresses glycogen 
synthesis, thereby increasing glucose metabolism to lactate and CO2.  If a specific β-AA 
is effective, then it should elicit an increase in lactate and CO2 production.  However, the 
known β3-AA, BRL 37344, only increased CO2 production in vitro, and did not affect 
lactate. 
During the 90-minute incubation period, the muscle strips released 
approximately 600 nmol lactate per 100 mg muscle.  Because 1 nmol glucose yields 2 
nmol of lactate, this represents 300 nmol glucose that was metabolized to lactate during 
the incubation period.  Bovine muscle contains approximately 70 µmol glycogen (as 
glucosyl units) per g, or 7 µmol (7,000 nmol) per 100 mg muscle (Crouse, Smith, and 
Prior, 1984; Crouse and Smith, 1986).  However, the incubation media contained 5 µM 
glucose, or 15,000 nmol per flask.  Thus, it is possible that the contribution of increased 
glycogen degradation to lactate production (caused by the ß3-AA) was masked lactate 
production from media glucose. 
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As indicated above, the ß3-AA BRL 37344 strongly increased CO2 production. A 
recent study demonstrated that an ERK-dependent pathway phosphorylates pyruvate 
dehydrogenase (PDH) and thereby inhibits its activity (Li et al., 2016). PDH catalyzes 
the first step in the Krebs cycle, converting pyruvate to acetyl-CoA. Therefore, 
activation of the ERK-dependent pathway would decrease CO2 production from glucose.  
The mechanism by which the ß3-AA increased CO2 is unknown, but may represent 
antagonism of the ERK-dependent pathway.  Hamby et al. (1986) also demonstrated that 
muscle from lambs treated with the ß-AA clenbuterol had greater CO2 production from 
glucose than muscle from control lambs.  
Also, if β-AA affects muscle metabolism, it should elicit a decrease in glycogen 
synthesis in the muscle.  Hamby et al. (1986) reported that clenbuterol treatment of 
lambs actually increased the in vitro conversion of glucose to glycogen (as well as to 
lactate).  However, the 35-d exposure to clenbuterol was sufficient to cause an increase 
in type II (glycolytic) myofibers (Hamby et al., 1986), explaining the increase in overall 
glucose metabolism. 
The findings in the current study demonstrate for the first time that the LL 
muscle contains β3-AR.  These results suggest that in live animal studies utilizing a β3-
AA (assuming that bovine adipose tissue contains β3-AR), there should be an increase 
lean muscle and decrease undesirable adipose tissue. 
In the study of Espinal et al. (1983), soleus muscles of exercised and exercise-
trained rats were incubated in different concentrations of insulin and a set amount of 14C 
glucose to detect metabolism.  Assuming norepinephrine was released during exercise, 
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the catecholamine caused the soleus muscles to increase lactate production, which is an 
indicator of increased glycolysis.  Hatefi et al. (2015) collected blood samples from 
castrated male goats fed ZH, a β2-AA, and reported a significant decrease in free glucose 
and free triacylglycerol concentrations in blood.  The decrease in blood triacylglycerol 
concentrations most likely represented decreased hepatic VLDL-cholesterol output. 
We would have expected an increase in blood glucose since these results would 
indicate that there was an increase in glycogen due to exposure of ZH.  However, data 
from Hatefi et al. (2015) indicated that carcasses from goats treated with ZH showed 
increased muscle mass and decreased adipose tissue deposition, possibly indicating that 
low blood glucose was due to glycose being used for energy production for muscle 
metabolism.  These data are in accordance with the results from the current study that β- 
AA increased muscle metabolism, and the response of muscle strips to BRL 37344 were 
similar to the β2-AA ZH. 
Another significant finding is that Experior did not behave like a β3-AA.  
Experior produced intermediate effects compared with the other two treatments.  The 
hypothesis for this study was to compare Experior and BRL 37344 function on muscle 
strips, and ideally would have expected similar results from the two β-AA.  If Experior is 
a β3-AA, it is not nearly as potent as BRL 37344. 
Viewing the results from the current study, the idea that Experior might actually 
be a β- antagonist should be discussed.  Mersmann (1998) proposed β1- and β2- 
antagonists could be agonists for β3-AR, suggesting a bidirectional pathway of β3-AA 
and antagonists. 
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Although glycogen and CO2 outputs from Experior were intermediate to the 
control and BRL 37344 samples, glycogen outputs were higher, and CO2 outputs were 
lower compared to BRL 37344.  Propranolol, a known β-antagonist, was given to adult 
men with type II diabetes mellitus.  Propranolol caused non-significant increase in 
fasting serum glucose levels, and significantly increased fasting serum glucose levels 
when propranolol was combined with hydrochlorothiazide treatments (Dornhorst, 
Powell, and Penskey, 1985).  Different outputs were collected from the latter compared 
to the current study, but both sets of data concluded that the metabolic condition of the 
men and muscle strips worsened because of propranolol and Experior, respectively. 
In an experiment conducted by McVeigh and Tarrant (1983), Friesian bulls 
received a treatment of propranolol immediately after they were mixed with other bulls 
that they were unfamiliar with socially.  Social mixing is extremely stressful for cattle 
since a hierarchy must be established.  Mixing caused an increase in epinephrine release 
in these bulls.  The two scientists did not see complete β-blocking by propranolol on the 
effects of epinephrine, but they did observe a depression in the effects of epinephrine.  
According to McVeigh and Tarrant (1983), there was a 63% breakdown of muscle 
glycogen in untreated bulls, while glycogen breakdown in treated bulls was only 55%.  
These data are similar to the data presented in the current study. 
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CHAPTER V 
SUMMARY 
Additional experiments that utilize in vitro metabolism and treating muscle strips 
are needed to confirm whether Experior is a β3-AA.  Comparison to a known β-
antagonist such as propranolol, along with β1-AA are needed as well.  Finally, an in vivo 
experiment comparing Experior, a known β3-AA such as BRL 37344, a known β2-AA, 
and a known β-antagonist is needed to confirm the mechanisms of Experior on 
metabolism in a living system.  
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